Showing results (111-120 of 153) with videos related to
Sort By:
Pageof 16
Scientific Reports|October 12, 2024
Perioperative gum-chewing training prevents a decrease in tongue pressure after esophagectomy in thoracic esophageal cancer patients: a nonrandomized trialReiko Yamanaka-Kohno, Yasuhiro Shirakawa, Aya Yokoi, et al.Scientific Reports|November 10, 2019
Visualization of epithelial-mesenchymal transition in an inflammatory microenvironment-colorectal cancer networkTakeshi Ieda, Hiroshi Tazawa, Hiroki Okabayashi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 3, 2023
[Clinical Outcome of Robot-Assisted Distal Pancreatectomy in Our Institutional Introduction]Hiroyoshi Matsukawa, Daisuke Satoh, Michihiro Ishida, et al.Esophagus : Official Journal of the Japan Esophageal Society|March 21, 2024
Japanese Classification of Esophageal Cancer, 12th Edition: Part IIYuichiro Doki, Koji Tanaka, Hiroshi Kawachi, et al.International Journal of Molecular Medicine|January 5, 2006
COX-2 induction by heparanase in the progression of breast cancerTakako Imada, Junji Matsuoka, Tetsuji Nobuhisa, et al.Molecular Cancer Therapeutics|January 14, 2009
Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumorKazufumi Sakurama, Kazuhiro Noma, Munenori Takaoka, et al.Surgical Case Reports|December 22, 2025
Laparoscopic Cholecystectomy for Acute Cholecystitis in a Patient with Acquired Hemophilia A: A Case Report of Perioperative Hemostatic Management with Plasma ExchangeKoki Yasui, Hiroaki Mashima, Hisakazu Nishimori, et al.European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatmentsYasuhiro Shirakawa, Hiroshi Tazawa, Shunsuke Tanabe, et al.Scientific Reports|January 19, 2021
Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancerRyoichi Katsube, Kazuhiro Noma, Toshiaki Ohara, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 14, 2025
[Two Cases of Conversion Surgery for Stage ⅣB Esophageal Cancer after Successful Immune Checkpoint Inhibitor (ICI) Therapy]Yohei Mizusawa, Yuki Katsura, Yasuhiro Shirakawa, et al.Pageof 16